Chaired by Vivian Yin and Navdeep Nijhawan.

This co-developed symposium featuring a thyroid eye disease debate is taking shape. We have confirmed four expert panelists representing the spectrum of treatment approaches, from traditional methods to newer biologics. The format will follow a presidential debate style, with structured presentations and moderated discussion periods. Dr. Yin and Dr. Nijhawan will co-moderate the session.

Breakfast will be served from 6:30 - 7:00 AM.

Learning Objectives

At the end of this session, participants will be able to:

1. To differentiate the different pathway targets for thyroid eye disease treatment.
2. To compare the efficacy of the different treatment modalities for TED.
3. To contrast the side effect of the different treatment modalities for TED.

CanMEDS: Scholar, Health Advocate, Medical Expert, Collaborator, Communicator, Leader

This session was co-developed by The Canadian Ophthalmological Society and Amgen and was planned to achieve scientific objectivity and balance.